Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -29.87% |
| 2024 | -10.99% |
| 2023 | -70.70% |
| 2022 | 147.27% |
| 2021 | 89.95% |
| 2020 | -31.44% |
| 2019 | 77.73% |
| 2018 | -55.70% |
| 2017 | 13.46% |
| 2016 | -36.78% |